SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

NYSE - LSE

CMSC	0.22%	22.44	$
RYCEF	-1.18%	17	$
RELX	-0.79%	33.08	$
RIO	1.25%	98.36	$
NGG	0.49%	90.765	$
BCE	-0.44%	23.785	$
BCC	-0.4%	80.26	$
VOD	-0.24%	15.812	$
RBGPF	-19.57%	69	$
JRI	0.69%	13.07	$
BP	1.26%	46.485	$
GSK	0.1%	58.42	$
CMSD	-0.04%	22.58	$
AZN	-0.18%	204.62	$
BTI	-0.2%	58.73	$

SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ECONOMY 29.12.2025

DENVER, CO / ACCESS Newswire / December 29, 2025 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,290,324 shares of its common stock (or pre-funded warrants in lieu thereof), Series C warrants to purchase up to an aggregate of 1,290,324 shares of common stock and Series D warrants to purchase up to an aggregate of 1,290,324 shares of common stock, at a purchase price of $1.55 per share (or pre-funded warrant in lieu thereof) and associated warrants. The warrants have an exercise price of $1.30 per share and are exercisable immediately upon issuance. The Series C warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series D warrants will expire twenty-four months after the effective date of the Resale Registration Statement.

Text size:

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. Aegis Capital Corp. received a cash tail fee.

The aggregate gross proceeds to the Company from the offering were approximately $2.0 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering (the "Resale Registration Statement").

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About SOBRsafe™
Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com.

Safe Harbor Statement
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, including statements regarding the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this news release. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.

Company Contact:
[email protected]

Investor Relations Contact:
Scott Liolios or Taylor Stadeli
Gateway Group
949-574-3860
[email protected]

SOURCE: SOBR Safe, Inc.

View the original press release on ACCESS Newswire

Th.Gonzalez--AT

Arizona Tribune - SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Featured

War's impact on fertilisers stirs food producer fears

US inflation surges to 3.3% as Iran war impact bites

Pay fears grow for US security workers in shutdown

US inflation surges 3.3% as Iran war impact bites